TRENDING : Top 50   TVIX (0%)    VXX (0%)    EEM (0%)    GM (0%)    MA (0%)    SPY (0%)    XLY (0%)    AMZN (0%)    BTCUSD (%)    CLBS (0%)    ABMD (0%)    AAPL (0%)    FB (0%)    GEVO (0%)    GS (0%)    IPGP (0%)    JD (0%)    NFLX (0%)    PEP (0%)    SEDG (0%)    SPX (0%)    EWI (0%)    CBIO (0%)    CARA (0%)    CANF (0%)

CRSP - CRISPR Therapeutics AG

$65.14 (0%)




RECENT SUCCESSFUL RECOMMENDATIONS

No recommendations found.

RECENT RECOMMENDATIONS

Stocks

No recommendations found.

Options

No recommendations found.


** Recommendations from last 7 days only. Subscribe to different services to see past recommendations

TRENDING ARTICLES



CRISPR Science and Stocks: Knowing Enough to Invest

NASDAQ NEWS   -  6/21/2018

2 High-Flying Biotech Stocks With Even More Room to Grow

NASDAQ NEWS   -  6/20/2018

Amgen Gets EU Nod to Add Survival Data on Blincyto's Label

NASDAQ NEWS   -  6/20/2018

Top Stock Picks for the Week of June 18, 2018

NASDAQ NEWS   -  6/18/2018

Is Gene Editing Dangerous? 4 Things You Should Know

NASDAQ NEWS   -  6/18/2018

BioMarin Begins Pediatric Study on Achondroplasia Candidate

NASDAQ NEWS   -  6/15/2018

Interesting CRSP Put And Call Options For July 27th

NASDAQ NEWS   -  6/15/2018

How to Play the New Hawkish Fed

NASDAQ NEWS   -  6/13/2018

Idera Stock Down, Study on Dermatomyositis Candidate Fails

NASDAQ NEWS   -  6/13/2018

Should CRISPR Stock Investors Worry About Cancer?

NASDAQ NEWS   -  6/13/2018

CRISPR Could Cause Cancer? Here Are 3 Reasons Investors Shouldn't Panic

NASDAQ NEWS   -  6/13/2018

Why Adient, CRISPR Therapeutics, and Applied Optoelectronics Slumped Today

NASDAQ NEWS   -  6/11/2018

Here's Why CRISPR Stocks are Getting Rocked Today

NASDAQ NEWS   -  6/11/2018

2 Cheap Growth Stocks to Buy Right Now

NASDAQ NEWS   -  6/11/2018

Here's Why the Top CRISPR Stocks Rose as Much as 47.1% in May

NASDAQ NEWS   -  6/8/2018

An Ear To The Pharma: 9 Stocks To Watch (CTMX, ZEAL, MRSN...)

NASDAQ NEWS   -  6/3/2018

CRSP Falls On Clinical Hold, PFE Gets FDA Nod, ARWR To Report Data In Nov.

NASDAQ NEWS   -  5/31/2018

A Glance At Potential Therapies For Sickle Cell Disease

NASDAQ NEWS   -  4/6/2018